Reminder - Marlin Business Services (MRLN) Goes Ex-Dividend Soon

Looking at the universe of stocks we cover at Dividend Channel, on 2/9/18, Marlin Business Services Corp (MRLN) will trade ex-dividend, for its quarterly dividend of $0.14, payable on 2/22/18. As a percentage of MRLN's recent stock price of $26.44, this dividend works out to approximately 0.53%, so look for shares of Marlin Business Services Corp to trade 0.53% lower — all else being equal — when MRLN shares open for trading on 2/9/18.

START SLIDESHOW:
Click here to learn which 25 S.A.F.E. dividend stocks should be on your radar screen »

Below is a dividend history chart for MRLN, showing historical dividends prior to the most recent $0.14 declared by Marlin Business Services Corp:

MRLN+Dividend+History+Chart

In general, dividends are not always predictable; but looking at the history above can help in judging whether the most recent dividend from MRLN is likely to continue, and whether the current estimated yield of 2.12% on annualized basis is a reasonable expectation of annual yield going forward. The chart below shows the one year performance of MRLN shares, versus its 200 day moving average:

Marlin Business Services Corp 200 Day Moving Average Chart

Looking at the chart above, MRLN's low point in its 52 week range is $20.26 per share, with $29.95 as the 52 week high point — that compares with a last trade of $26.44.

In Wednesday trading, Marlin Business Services Corp shares are currently up about 0.5% on the day.

More from Stocks

Markets Push Higher Following Fed Chair's First Testimony on Capitol Hill

Markets Push Higher Following Fed Chair's First Testimony on Capitol Hill

Elon Musk's Tweeting Obsession Is Crushing Tesla Stock Believers

Elon Musk's Tweeting Obsession Is Crushing Tesla Stock Believers

Tesla's Model 3 Teardown Shows It Is Already Profitable - Really Profitable

Tesla's Model 3 Teardown Shows It Is Already Profitable - Really Profitable

J&J Vows to Fight Verdict Linking Baby Powder to Ovarian Cancer

J&J Vows to Fight Verdict Linking Baby Powder to Ovarian Cancer

Jerome Powell's Testimony Isn't Changing This Strategist's 3,000 S&P 500 Target

Jerome Powell's Testimony Isn't Changing This Strategist's 3,000 S&P 500 Target